$160.00
Retatrutide in a pre-filled 40mg pen device. A triple agonist at the GIP, GLP-1 and glucagon receptors, investigational rather than approved anywhere. The pen format delivers a fixed dose per click, which is a different proposition from a vial and syringe.
| SKU | ALV-RETA-40MG-PEN |
|---|---|
| Manufacturer | Alluvi |
| Batch code | Not published for this batch |
| Assay purity | Not published for this batch |
| Issuing laboratory | Not stated |
| Certificate | Not yet published |
| Storage | 15–25°C, away from light |
| Dispatch | Ships same business day from Osteen, FL |
Retatrutide in a pre-filled 40mg pen device. A triple agonist at the GIP, GLP-1 and glucagon receptors, investigational rather than approved anywhere. The pen format delivers a fixed dose per click, which is a different proposition from a vial and syringe.
Reviews
There are no reviews yet.